148 related articles for article (PubMed ID: 15368444)
21. [In vivo apoptotic effect of alpha-2b interferon (IFN) on rat preneoplastic liver ].
Alvarez ML; Cerliani JP; Monti JA; Carnovale CE; Ronco T; Pellegrino JM; Pisani G; Lugano C; Carrillo MC
Medicina (B Aires); 2001; 61(5 Pt 2):666-9. PubMed ID: 12058585
[TBL] [Abstract][Full Text] [Related]
22. Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes.
Díez-Fernández C; Andrés D; Cascales M
Free Radic Biol Med; 2002 Sep; 33(6):835-46. PubMed ID: 12208371
[TBL] [Abstract][Full Text] [Related]
23. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells.
Sumiyoshi K; Nakao A; Setoguchi Y; Tsuboi R; Okumura K; Ogawa H
J Dermatol Sci; 2003 Feb; 31(1):53-8. PubMed ID: 12615364
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
26. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
Park DY; Hwang SY; Suh KS
Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
[TBL] [Abstract][Full Text] [Related]
27. Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes.
Herrera B; Fernández M; Alvarez AM; Roncero C; Benito M; Gil J; Fabregat I
Hepatology; 2001 Sep; 34(3):548-56. PubMed ID: 11526541
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver.
Jeong WI; Do SH; Yun HS; Song BJ; Kim SJ; Kwak WJ; Yoo SE; Park HY; Jeong KS
Liver Int; 2004 Dec; 24(6):658-68. PubMed ID: 15566519
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
[TBL] [Abstract][Full Text] [Related]
30. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
32. Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.
Liu C; Gaça MD; Swenson ES; Vellucci VF; Reiss M; Wells RG
J Biol Chem; 2003 Mar; 278(13):11721-8. PubMed ID: 12547835
[TBL] [Abstract][Full Text] [Related]
33. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
34. [Expression of TGF-beta1/Smad protein in rat liver fibrosis model and the role of IFN-gamma].
Fu XQ; Liu SR; Guo JC; Bao JF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):340-3. PubMed ID: 24645317
[TBL] [Abstract][Full Text] [Related]
35. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
36. Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells.
Zhao JF; Liu CH; Hu YY; Xu LM; Liu P; Liu C
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):102-5. PubMed ID: 14969849
[TBL] [Abstract][Full Text] [Related]
37. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
38. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells.
Okado T; Terada Y; Tanaka H; Inoshita S; Nakao A; Sasaki S
Kidney Int; 2002 Oct; 62(4):1178-86. PubMed ID: 12234288
[TBL] [Abstract][Full Text] [Related]
39. Resistance to TGF-beta1-mediated growth inhibition correlates with sustained Smad2 phosphorylation in primary murine splenocytes.
Feldmann K; Sebald W; Knaus P
Eur J Immunol; 2002 May; 32(5):1393-402. PubMed ID: 11981827
[TBL] [Abstract][Full Text] [Related]
40. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
